Low Down's ultrasound availability under review:
This article was originally published in Clinica
Executive Summary
The nuchal translucency test used in antenatal screening to help assess the risk of Down's syndrome is available in only 8% of UK maternity units, says the government. Wider availability of the ultrasound scanning technique, in combination with first trimester blood serum screening is being "kept under review", health secretary Jacqui Smith maintains. Current screening policy, as advocated by the National Screening Committee (NSC), is that all women be offered second trimester serum screening, consisting of at least a double test - ie screening for two markers. The NSC also recommends moving "towards triple or quadruple tests when possible," Ms Smith told Parliament last week.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.